At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Tixel Cdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Efficacy and Safety of a Thermal Fractional Skin Treatment System (TIXEL®) for the Treatment of Facial and / or Scalp Actinic Keratoses.
In Brief
A clinical study evaluating Tixel C for Actinic Keratoses. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Evaluation of the Efficacy and Safety of a thermal fractional skin treatment system (Tixel) for the treatment of facial and/or scalp actinic keratoses
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActinic Keratoses
CountriesIsrael
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedMay 2022
Enrollment StartMay 2022
Primary CompletionSep 2023
TodayJul 2026
First PostedMay 9, 2022
Enrollment StartMay 17, 2022
Primary CompletionSep 12, 2023
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.1 years ago
Interventions
Tixel Cdevice
This is a non-invasive thermo-mechanical treatment to the scalp and/or face using the Tixel technology.